Delivery Order SPE2DB22D3501-SPE2DB25FXH97
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $64,765.81 on September 8, 2025, for the supply of Queliptta 60 mg tablets (30-count) with an ultimate completion date of October 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,651.43 to AmerisourceBergen Drug Corp for the supply of Quelipita 60 mg tablets (30-count packages) on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is being performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units) under a firm fixed-price contract valued at $10,307.65. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a leading...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qualiptа 60 mg tablets (30-count) with a firm fixed price structure. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $20,000 to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units). The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through...
- The Defense Logistics Agency (DLA) awarded a $3,134.47 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,036.88 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH97Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,589.51 to AmerisourceBergen Drug Corp for 30 tablets of Quelipti 60 mg, a pharmaceutical product used in mental health treatment. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with an ultimate completion date of September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad portfolio of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. The company's recurring delivery orders across multiple therapeutic domains and product types demonstrate its critical role in maintaining pharmaceutical supply chains for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/15/25 |